Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Stock in Focus After Reverse Stock Split
Clinical-stage biopharmaceutical company, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), announced that it will effect a 1-for-32 reverse stock split of its outstanding common stock, on May 16, 2022. Trading Data On Monday, TNXP stock slumped 31.36% to $0.0904 with more than 104.06 million shares, compared to its average volume of 31.04 million shares. The stock moved within a range of $0.0881 – 0.1337 after opening trade at $0.1337. The reverse stock…